More than a third of the 8.7 million "zero-dose" children in Africa live in Nigeria and Ethiopia, where conflict, instability, poverty, climate change, and misinformation are disrupting vaccination campaigns, according to the World Health Organization.
Now, drugmaker GlaxoSmithKline and Save the Children are renewing their 10-year partnership, which will focus on reducing the number of children who have never received any routine vaccinations, the Guardian reports.
"No child should die from a vaccine preventable disease," Save the Children's country director in Ethiopia says.
"Yet the number of cases and the mortality rate from such diseases, like cholera and measles, are on the rise in Ethiopia and there is an urgent need to address the barriers stopping children from being able to access routine vaccination."
The two organizations will work together to develop two world-class programs in Nigeria and Ethiopia to help more children get the vaccinations they need to help stay healthy, according to a press release.
"None of this is possible without global partnership and we look forward to working with GSK and Save the Children in this effort," the Ethiopian minister of health says.
A customized collection of grant news from foundations and the federal government from around the Web.
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.